GlobalFoundries Reports Third Quarter 2025 Financial Results

(NASDAQ:GFS), MALTA, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) — GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the third quarter ended September 30, 2025. Key Third Quarter Financial Highlights Revenue of $1.688 billion Gross margin of 24.8% and Non-IFRS gross margin(1) of 26.0% Operating margin of 11.6% and Non-IFRS operating margin(1) of […]

Yitahome Launches Black Friday Campaign “Find Your Holiday Glow” to Brighten This Season

As the holiday season approaches, Yitahome invites everyone to embrace warmth, comfort, and festive charm with its Black Friday campaign, “Find Your Holiday Glow.” This year's campaign centers on crafting purposeful, heartfelt spaces-joyful, welcoming, and deeply personal-whether you're hosting holiday gatherings, enjoying cozy movie nights, or simply refreshing your home for the season ahead. From

AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

(NasdaqGM:ATON), Dover, DE and Sydney, Australia, Nov. 12, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics (Cyncado), today announced a non-binding Letter of Intent (LOI) between Australia's Asbestos and Dust Diseases Research Institute (ADDRI) and Tarus Therapeutics, LLC to conduct an

Transom Acquires Binswanger Glass, Accelerating Next Phase of Growth for Leading U.S. Glazing Company

LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) — Transom Capital Group (“Transom”), a Los Angeles-based private equity firm specializing in operational transformation, today announced the completion of its acquisition of Binswanger Glass (“Binswanger” or the “Company”), one of the largest and most experienced full-service flat glass companies in the United States. The partnership brings new

e-STORAGE to Deliver 1.86 GWh DC of Energy Storage Solutions for the Skyview 2 Project in Ontario, Canada

Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced that e-STORAGE, part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. (“CSI Solar”), has been contracted to provide a fully integrated energy storage solution and turnkey Engineering, Procurement, and Construction (EPC) services for the 411 MW/1,858 MWh Skyview 2 Energy Storage Project

Climb Channel Solutions Announces Strategic Partnership with Liongard

(NasdaqGM:CLMB), EATONTOWN, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is excited to announce a strategic partnership with Liongard, a leader in asset intelligence and automation. This collaboration aims to enhance the capabilities of managed service providers

OTC Markets Group Welcomes District Metals Corp. to OTCQX

(Other OTC:OTCM),(OTC US:OTCM),(TSX-V:DMX),(Other OTC:DMXCF), NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced District Metals Corp. (TSX-V: DMX; OTCQX: DMXCF), a disciplined, science-based exploration and development company, has qualified to trade on the OTCQX(R) Best Market. District

Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER(R)) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps

(NASDAQ:IMTX), Company to host conference call and webcast today, November 12, at 8:30 am EST/2:30 pm CET IMA402 and IMA401 TCR Bispecifics showed favorable tolerability at RP2D as well as deep and durable responses in heavily pre-treated, last-line patients with a range of solid tumors IMA402 PRAME Bispecific at RP2D range resulted in a 30%

Sitryx presents new preclinical data highlighting PKM2 as a promising metabolic target for the treatment of atopic dermatitis at the Inflammatory Disease Skin Summit 2025

Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis pathology SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease remission in autoimmune diseases, with a Phase 1b trial in atopic dermatitis patients expected to begin in Q1 2026 Sitryx is proud to sponsor the 6th Inflammatory Skin Disease

e-STORAGE Secures a Battery Energy Storage Project in Germany as Part of its European Expansion

Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced that e-STORAGE, part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. (“CSI Solar”), has signed a Battery Energy Storage System (BESS) Supply Agreement for a 20.7 MW / 56 MWh DC energy storage project in Lower Saxony, Germany. The agreement also includes

Scroll to Top